Viewing Study NCT02892695

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:28 PM
Ignite Modification Date: 2026-05-30 @ 3:55 PM
Study NCT ID: NCT02892695
Status: UNKNOWN
Last Update Posted: 2016-12-06
First Post: 2016-09-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphocytic Leukemia View
None Chronic Lymphocytic Leukemia View
None Follicular Lymphoma View
None Mantle Cell Lymphoma View
None B-cell Prolymphocytic Leukemia View
None Diffuse Large Cell Lymphoma View
Keywords: